Salvage oesophagectomy after local failure of definitive chemoradiotherapy

被引:76
作者
Gardner-Thorpe, J. [1 ]
Hardwick, R. H. [1 ]
Dwerryhouse, S. J. [1 ]
机构
[1] Addenbrookes Hosp, Oesophagogastr Ctr, Cambridge CB2 2QQ, England
关键词
D O I
10.1002/bjs.5865
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Definitive chemoradiotherapy (CRT) is one treatment option for locally advanced oesophageall carcinoma. CRT typically consists of high-dose (50-66 Gy) external beam radiotherapy concurrent with 5-fluorouracil and cisplatin. When definitive CRT fails to achieve local control, salvage oesophagectomy is frequently the only treatment available that can offer a chance of long-term survival. Methods: Online databases were searched for publications relating to salvage oesophagectomy and definitive CRT. Nine series containing a total of 105 patients were reviewed. Demographics, indications for surgery, type of resection, complications and outcome data were extracted. Results: Each centre performed one to three salvage resections per year comprising 1.7-4.1 per cent of the oesophagectomy workload. The overall anastomotic leak rate was 17.1 per cent. The in-hospital mortality rate was 11.4 per cent. Five-year survival rates of 25-35 per cent were achieved. Prognostic factors for increased survival were R0 resection (P = 0.006) and longer interval between CRT and recurrence (P = 0.002). Conclusion:. Salvage resection after CRT is feasible for selected patients but is a formidable undertaking. Restaging investigations after CRT for potentially resectable tumours in fit candidates should include endoscopy and positron emission tomography-computed tomography. Salvage oesophagectomy is carried out with the goal of cure and it should be attempted only if an RO resection is technically possible.
引用
收藏
页码:1059 / 1066
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2002, CLASSIFICATION MALIG
[2]  
Bancewicz J, 2002, LANCET, V359, P1727
[3]   Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma [J].
Bates, BA ;
Detterbeck, FC ;
Bernard, SA ;
Qaqish, BF ;
Tepper, JE .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :156-163
[4]  
Beseth BD, 2000, AM SURGEON, V66, P827
[5]   A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102):: chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer [J].
Bonnetain, F ;
Bouché, O ;
Michel, P ;
Mariette, C ;
Conroy, T ;
Pezet, D ;
Roullet, B ;
Seitz, JF ;
Paillot, B ;
Arveux, P ;
Milan, C ;
Bedenne, L .
ANNALS OF ONCOLOGY, 2006, 17 (05) :827-834
[6]   Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 patterns of care study [J].
Coia, LR ;
Minsky, BD ;
Berkey, BA ;
John, MJ ;
Haller, D ;
Landry, J ;
Pisansky, TM ;
Willett, CG ;
Hoffman, JP ;
Owen, JB ;
Hanks, GE .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :455-462
[7]   Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01) [J].
Cooper, JS ;
Guo, MD ;
Herskovic, A ;
Macdonald, JS ;
Martenson, JA ;
Al-Sarraf, M ;
Byhardt, R ;
Russell, AH ;
Beitler, JJ ;
Spencer, S ;
Asbell, SO ;
Graham, MV ;
Leichman, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1623-1627
[8]  
Daly JM, 1996, CANCER, V78, P1820, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO
[9]  
2-Z
[10]   Factors influencing outcome following radio-chemotherapy for oesophageal cancer [J].
Denham, JW ;
Burmeister, BH ;
Lamb, DS ;
Spry, NA ;
Joseph, DJ ;
Hamilton, CS ;
Yeoh, E ;
OBrien, P ;
Walker, QJ .
RADIOTHERAPY AND ONCOLOGY, 1996, 40 (01) :31-43